Solano, Maria
3624  Ergebnisse:
Personensuche X
?
 
?
5

Methodology improvement in the performance of production sy..:

Solano, María A ; Juan J. Bravo, Juan J. Bravo ; Giraldo, Jaime A
https://revistas.univalle.edu.co/index.php/ingenieria_y_competitividad/article/view/2653/3502.  , 2013
 
?
9

Guía de manejo para el tratamiento de la Leucemia linfoide ..:

Figueroa Camacho, Javier Leonardo ; Solano, María Helena ; Villamizar Gómez, Licet
Greer J, Foerster J, Luken J, editors. Wintrobe's clinical hematology. 2th ed. Philadelphia : Lippincott Williams and Wilkins; 2004. 2. Pui CH, Evans WE. Treatment ofacute lymphoblastic leukemia. N Engl J Med. 2006 Jan 12; 354(2): 166-78. 3. Gokbuget N, Hoelzer D. Treatment ofadult acule lymphoblastic leukemia. HematologyAm Soc Hematol Educ Program. 2006;133-41. 4. Hoeltzer D, GoKbuget N. Treatment ofadult acule lymphoblastic leukemia. Hematology. 2006;1: 162-92. 5. Enciso L, Rodríguez M, et al. Consensocolombiano sobre el tratamiento de la leucemia linfoblástica aguda en adultos. Rev Colomb Cancero! 2006;10(1):7-35. 6. Rowe J. How I treat acute Lymphoblastic Leukemia in Adults. Blood 2007;1!0(7): 2268-75 7. Scottish Intercollegiale Guideline Network. SIGN 50: a guideline developers' handbook. Edinburgh: SIGN; 2008. 8. TheAGREE Collaboration.Appraisal ofGuidelines for Research & Evaluation (AGREE) lnstrument. London: AGREE; 2003. 9. Hoelzer D, Gokbugel N. Tre....  , 2022
 
?
11

Leucemia mieloide crónica: Un modelo terapéutico de biologí..:

Suárez Delgado, Sandra Lucía ; Polo, Virginia Abello ; Solano, María Helena
Kantarjian H. Chronic Myelogenous leukemia: disease biology and current and future therapeutic strategies. American Society of Hematology 2000: 90-107..  , 2022
 
?
12

Experiencia de validación de material educativo pacientes a..:

Solano, Maria Helena
Dupras D, Bluhm J, Felty C, et al. Institute for Clinical Systems Improvement. Health care guideline: venous thromboembolism diagnosis and treatment. Updated: January, 2013. www.icsi.org/_asset/5ldx9k/VTE0113.pdf 2. Flores Gutiérrez, M. Factores de riesgo en enfermedad tromboembólica venosa. Ortho-tips Vol. 4 No. 2 2008 www.medigraphic.com/pdfs/orthotips/ot-2008/ot082c.pdf 3. Goldman L, Schafer A. Trastornos trombóticos: estados de hipercoagulabilidad. In: Elseiver, editor. Cecil y Goldman Tratado de medicina interna 179 2013. p. 1152-8. 4. Goldhaber S. Risk Factors for Venous Thromboembolism. Journal of the American College of Cardiology; 2010. p. 1-7. 5. Guyatt G, Elie A, Crowther M, Gutterman D, Schü H. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest; 2012. p. 7-47. 6. Leewen V, Rosendaal FR, Cannegieter C. Prediction of hemorrhagic and thrombotic eve....  , 2022
 
?
13

Adherencia al tratamiento anticoagulante: Hospital de San J..:

Solano, Maria Helena ; Mendieta, Felipe Andrés
Nutescu EA. The future of anticoagulation clinics. J Thromb Thrombolysis. 2003;16(1-2):61-3..  , 2022
 
1-15